1） Ward J: Vital pulp therapy in cariously exposed permanent teeth and its limitations. Aust Endod J 28: 29-37, 2002.
2） Takahashi K: Changes in the pulpal vasculature during inflammation. J Endod 16: 92-7, 1990.
3） Gronthos S, Brahim J, Li W, et al: Stem cell properties of human dental pulp stem cells. J Dent Res 81: 531-535, 2002.
4） Cox CF, Tarim B, Kopel H, et al: Technique sensitivity: biological factors contributing to clinical success with various restorative materials. Adv Dent Res 15: 85-90, 2001.
5） Armelin H A: Pituitary extracts and steroid hormones in the control of 3T3 cell growth. Proc. Natl. Acad. Sci. (U. S. A.) 70: 2702-2706, 1973.
6） Gospodarowicz D: Purification of fibroblast growth factor from bovine pituitary. J. Biol. Chem. 250: 2515-2520, 1975.
7） Cuevas R, Burgos J，Baird A： Basic fibroblast growthfactor （FGF）promotes cartilage repair in vivo.Biochem Biophys Res Commun 156: 611− 618,1988.
8） Globus R K，Plouet J，Gospodarowicz D： Cultured bovine bone cells synthesize basic fibroblast growth factor and store it in their extracellular matrix. Endocrinology 124: 1539−1547, 1989．
9） Sato Y，Shimada T，Takaki R： Autocrinological role of basic fibroblast growth factor on tube formation of vascular endethelial cells in vitro. Biochem Biophys Res Commun 180: 1098−1102, 1991.
10） Takayama S，Yoshida J， Hirano H , et al: Effects of basic fibroblast growth factor on human gingival epithelial cells. J Periodontol 73: 1467−1473，2002.
11） Akita S, Akino K, Imaizumi T, et al: Basic fibroblast growth factor accelerates and improves second-degree burn wound healing. Wound Repair Regen 16: 635-41, 2008.
12） Murakami S: Periodontal tissue regeneration by signaling molecule(s): what role does basic fibroblast growth factor (FGF-2 have in periodontal therapy? Periodontol 2001, 56: 188-208, 2011.
13） Yoshiba K, Yoshiba N, Nakamura H, et al: Immunolocalization of fibronectin during reparative dentinogenesis in human teeth after pulp capping with calcium hydroxide. J Dent Res 75: 1590-7, 1996.
14） Zarrabi M H, Javidi, M, Jafarian, A H, et al: Immunohistochemical expression of fibronectin and tenascin in human tooth pulp capped with mineral trioxide aggregate and a novel endodontic cement. J Endod 37: 1613-8, 2011.
15） Chong B S, Pitt Ford T R, Hudson M B: A prospective clinical study of Mineral Trioxide Aggregate and IRM when used as root-end filling materials in endodontic surgery.2003. Int Endod J 42: 414- 20, 2009.
16） Main C, Mirzayan, N, Shabahang S, Torabinejad M: Repair of root perforations using mineral trioxide aggregate: a long-term study. J Endod 30: 80-3,2004.
17） Mente J, Geletneky B, Ohle M, et al: Mineral trioxide aggregate or calcium hydroxide direct pulp capping: an analysis of the clinical treatment outcome. J Endod 36: 806-13, 2010.
18） Camilleri J & Pitt Ford T. R: Mineral trioxide aggregate: a review of the constituents and biological properties of the material. International Endodontic Journal 39: 747–754, 2006.
19） Graham L, Cooper P, Cassidy N, et al.: The effect of calcium hydroxide on solubilization of bioactive dentin matrix components, Biomaterials, 27: 2865-2873, 2006.
20） Tomson PL, Grover LM, Lumley PJ, et al: Dissolution of bio- active dentin matrix components by mineral trioxide aggregate. J Dent 35: 636-642, 2007.
21） Laurent P, Camps J, De Méo MLaurent, et al: Induction of specific cell responses to a Ca(3)SiO(5)-based posterior restorative material. Dent Mater 24:1486-94, 2008.
22） Okiji T, Yoshiba K: Reparative dentinogenesis induced by mineral trioxide aggregate: a review from the biological and physicochemical points of view. Int J Dent 2009: 464280, 2009.
23） Tabata Y, Nagano A. Ikada Y, et al: Biodegradation of hydrogel carrier incorporating fibroblast growth factor. Tissue Eng 5: 127- 38, 1999.
24） Ishimatsu H, Kitamura C. Morotomi T, et al: Formation of dentinal bridge on surface of regenerated dental pulp in dentin defects by controlled release of fibroblast growth factor-2 from gelatin hydrogels. J Endod 35: 858-65, 2009.
25） Kikuchi N. Kitamura C. Morotomi T, et al: Formation of dentin- like particles in dentin defects above exposed pulp by controlled release of fibroblast growth factor 2 from gelatin hydrogels. J Endod 33: 1198-202, 2007.
26） 石橋眞澄著: 歯内療法学論考,末永書店：11-16,1987.
27） Samuel Seltzer/I.B.Bender 著: 戸田忠夫監訳: 医歯薬出版株式会社: 129, 1988.
28） Hilton, T.J: Keys to clinical success with pulp capping: a review of the literature. Oper Dent 34: 615-25, 2009.
29） Torabinejad M, Parirokh M: Mineral trioxide aggregate: a comprehensive literature review--part II: leakage and biocompatibility investigations. J Endod 36: 190-202, 2010.
30） Kuratate M, Yoshiba K, Shigetani Y, Yoshiba N, Ohshima H, and Okiji T: Immunohistochemical analysis of nestin, osteopontin, and proliferating cells in the reparative process of exposed dental pulp capped with mineral trioxide aggregate. J Endod, 34: 970-974, 2008
31） Eiichi Yoshii: Cytotoxic effects of acrylates and methacrylates: relationships of monomer structures and cytotoxicity. Journal of Biomedical materials Research 37: 517-524, 1997.
32） Syngcuk Kim, Jutta Dörscher Kim MA: Hemodynamic regulation of the dental pulp in a low compliance environment. Journal of Endodontics 15: 404-408, 1989.
論文の公開元へ
